| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RRAS2 DNAH10 ATP8A2 DNAH2 DHX57 RAB40A HELB IQCA1L IQCA1 RAB40AL RAB40B AGAP7P AGAP4 RAB4A AGAP6 | 2.43e-04 | 775 | 135 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 2.70e-04 | 4 | 135 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | aliphatic amine oxidase activity | 2.70e-04 | 4 | 135 | 2 | GO:0052595 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 3.14e-04 | 190 | 135 | 7 | GO:0004252 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 5.25e-04 | 207 | 135 | 7 | GO:0008236 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RRAS2 DNAH10 ATP8A2 DNAH2 DHX57 RAB40A HELB IQCA1L IQCA1 RAB40AL RAB40B AGAP7P AGAP4 RAB4A AGAP6 | 5.59e-04 | 839 | 135 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RRAS2 DNAH10 ATP8A2 DNAH2 DHX57 RAB40A HELB IQCA1L IQCA1 RAB40AL RAB40B AGAP7P AGAP4 RAB4A AGAP6 | 5.65e-04 | 840 | 135 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RRAS2 DNAH10 ATP8A2 DNAH2 DHX57 RAB40A HELB IQCA1L IQCA1 RAB40AL RAB40B AGAP7P AGAP4 RAB4A AGAP6 | 5.65e-04 | 840 | 135 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | serine hydrolase activity | 6.05e-04 | 212 | 135 | 7 | GO:0017171 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 6.69e-04 | 6 | 135 | 2 | GO:0048763 | |
| GeneOntologyCellularComponent | aggresome | 1.16e-04 | 40 | 132 | 4 | GO:0016235 | |
| Domain | HELP | 6.80e-06 | 6 | 132 | 3 | PF03451 | |
| Domain | HELP | 6.80e-06 | 6 | 132 | 3 | IPR005108 | |
| Domain | P_proprotein | 1.18e-05 | 7 | 132 | 3 | PF01483 | |
| Domain | S8_pro-domain | 1.18e-05 | 7 | 132 | 3 | IPR032815 | |
| Domain | PrprotnconvertsP | 1.18e-05 | 7 | 132 | 3 | IPR002884 | |
| Domain | - | 1.18e-05 | 7 | 132 | 3 | 3.30.70.850 | |
| Domain | S8_pro-domain | 1.18e-05 | 7 | 132 | 3 | PF16470 | |
| Domain | Peptidase_S8_His-AS | 2.81e-05 | 9 | 132 | 3 | IPR022398 | |
| Domain | Peptidase_S8_Ser-AS | 2.81e-05 | 9 | 132 | 3 | IPR023828 | |
| Domain | Peptidase_S8_subtilisin-rel | 3.99e-05 | 10 | 132 | 3 | IPR015500 | |
| Domain | SUBTILASE_ASP | 3.99e-05 | 10 | 132 | 3 | PS00136 | |
| Domain | SUBTILASE_HIS | 3.99e-05 | 10 | 132 | 3 | PS00137 | |
| Domain | SUBTILASE_SER | 3.99e-05 | 10 | 132 | 3 | PS00138 | |
| Domain | - | 5.46e-05 | 11 | 132 | 3 | 3.40.50.200 | |
| Domain | Peptidase_S8/S53_dom | 5.46e-05 | 11 | 132 | 3 | IPR000209 | |
| Domain | Peptidase_S8 | 5.46e-05 | 11 | 132 | 3 | PF00082 | |
| Domain | Oxysterol-bd_CS | 7.25e-05 | 12 | 132 | 3 | IPR018494 | |
| Domain | Oxysterol_BP | 7.25e-05 | 12 | 132 | 3 | PF01237 | |
| Domain | Oxysterol-bd | 7.25e-05 | 12 | 132 | 3 | IPR000648 | |
| Domain | OSBP | 7.25e-05 | 12 | 132 | 3 | PS01013 | |
| Domain | Ryanodine_rcpt | 1.48e-04 | 3 | 132 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 1.48e-04 | 3 | 132 | 2 | IPR009460 | |
| Domain | RyR | 1.48e-04 | 3 | 132 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.48e-04 | 3 | 132 | 2 | PF06459 | |
| Domain | Ryan_recept | 1.48e-04 | 3 | 132 | 2 | IPR013333 | |
| Domain | Propept_inh | 2.18e-04 | 17 | 132 | 3 | IPR009020 | |
| Domain | SOCS | 3.60e-04 | 20 | 132 | 3 | SM00253 | |
| Domain | EGF-like_dom | 3.97e-04 | 249 | 132 | 8 | IPR000742 | |
| Domain | Quinoprotein_ADH-like_supfam | 5.34e-04 | 53 | 132 | 4 | IPR011047 | |
| Domain | RIH_assoc-dom | 7.30e-04 | 6 | 132 | 2 | IPR013662 | |
| Domain | GF_recep_IV | 7.30e-04 | 6 | 132 | 2 | PF14843 | |
| Domain | GF_recep_IV | 7.30e-04 | 6 | 132 | 2 | IPR032778 | |
| Domain | Peptidase_S8_Asp-AS | 7.30e-04 | 6 | 132 | 2 | IPR023827 | |
| Domain | Ins145_P3_rec | 7.30e-04 | 6 | 132 | 2 | PF08709 | |
| Domain | RIH_assoc | 7.30e-04 | 6 | 132 | 2 | PF08454 | |
| Domain | RIH_dom | 7.30e-04 | 6 | 132 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 7.30e-04 | 6 | 132 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 7.30e-04 | 6 | 132 | 2 | IPR015925 | |
| Domain | - | 7.30e-04 | 6 | 132 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 7.30e-04 | 6 | 132 | 2 | PF01365 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.36e-04 | 106 | 132 | 5 | IPR000152 | |
| Domain | ArfGap | 1.10e-03 | 29 | 132 | 3 | SM00105 | |
| Domain | ARFGAP | 1.10e-03 | 29 | 132 | 3 | PS50115 | |
| Domain | ArfGap | 1.10e-03 | 29 | 132 | 3 | PF01412 | |
| Domain | ArfGAP | 1.10e-03 | 29 | 132 | 3 | IPR001164 | |
| Domain | DWB | 1.35e-03 | 8 | 132 | 2 | SM00524 | |
| Domain | MH2 | 1.35e-03 | 8 | 132 | 2 | PS51076 | |
| Domain | MH1 | 1.35e-03 | 8 | 132 | 2 | PS51075 | |
| Domain | DHC_N1 | 1.35e-03 | 8 | 132 | 2 | PF08385 | |
| Domain | - | 1.35e-03 | 8 | 132 | 2 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 1.35e-03 | 8 | 132 | 2 | IPR013019 | |
| Domain | Dwarfin | 1.35e-03 | 8 | 132 | 2 | IPR013790 | |
| Domain | MH2 | 1.35e-03 | 8 | 132 | 2 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 1.35e-03 | 8 | 132 | 2 | IPR001132 | |
| Domain | Dynein_heavy_dom-1 | 1.35e-03 | 8 | 132 | 2 | IPR013594 | |
| Domain | EGF | 1.42e-03 | 235 | 132 | 7 | SM00181 | |
| Domain | EGF_CA | 1.75e-03 | 122 | 132 | 5 | SM00179 | |
| Domain | RAB | 1.78e-03 | 73 | 132 | 4 | PS51419 | |
| Domain | EGF-like_Ca-bd_dom | 1.88e-03 | 124 | 132 | 5 | IPR001881 | |
| Domain | MIR | 2.15e-03 | 10 | 132 | 2 | PF02815 | |
| Domain | MIR_motif | 2.15e-03 | 10 | 132 | 2 | IPR016093 | |
| Domain | MIR | 2.15e-03 | 10 | 132 | 2 | PS50919 | |
| Domain | MIR | 2.15e-03 | 10 | 132 | 2 | SM00472 | |
| Domain | Ig_I-set | 2.33e-03 | 190 | 132 | 6 | IPR013098 | |
| Domain | I-set | 2.33e-03 | 190 | 132 | 6 | PF07679 | |
| Domain | SOCS_box | 2.43e-03 | 38 | 132 | 3 | PF07525 | |
| Domain | SOCS_box | 2.62e-03 | 39 | 132 | 3 | SM00969 | |
| Domain | SOCS_box | 2.62e-03 | 39 | 132 | 3 | IPR001496 | |
| Domain | SOCS | 2.62e-03 | 39 | 132 | 3 | PS50225 | |
| Domain | Ras | 2.81e-03 | 136 | 132 | 5 | PF00071 | |
| Domain | MAD_homology1_Dwarfin-type | 3.12e-03 | 12 | 132 | 2 | IPR003619 | |
| Domain | DWA | 3.12e-03 | 12 | 132 | 2 | SM00523 | |
| Domain | MH1 | 3.12e-03 | 12 | 132 | 2 | PF03165 | |
| Domain | EGF_CA | 3.24e-03 | 86 | 132 | 4 | PF07645 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.27e-03 | 14 | 132 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.27e-03 | 14 | 132 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.27e-03 | 14 | 132 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.27e-03 | 14 | 132 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.27e-03 | 14 | 132 | 2 | IPR011704 | |
| Domain | PLAC | 4.27e-03 | 14 | 132 | 2 | PF08686 | |
| Domain | MT | 4.27e-03 | 14 | 132 | 2 | PF12777 | |
| Domain | AAA_8 | 4.27e-03 | 14 | 132 | 2 | PF12780 | |
| Domain | CNH | 4.27e-03 | 14 | 132 | 2 | SM00036 | |
| Domain | AAA_5 | 4.27e-03 | 14 | 132 | 2 | PF07728 | |
| Domain | DHC_fam | 4.90e-03 | 15 | 132 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 4.90e-03 | 15 | 132 | 2 | PF03028 | |
| Domain | Pept_M10A_Zn_BS | 4.90e-03 | 15 | 132 | 2 | IPR021158 | |
| Domain | CNH | 4.90e-03 | 15 | 132 | 2 | PF00780 | |
| Domain | Dynein_heavy_dom | 4.90e-03 | 15 | 132 | 2 | IPR004273 | |
| Domain | CNH | 4.90e-03 | 15 | 132 | 2 | PS50219 | |
| Domain | CNH_dom | 4.90e-03 | 15 | 132 | 2 | IPR001180 | |
| Domain | EGF_Ca-bd_CS | 4.98e-03 | 97 | 132 | 4 | IPR018097 | |
| Domain | Growth_fac_rcpt_ | 5.04e-03 | 156 | 132 | 5 | IPR009030 | |
| Domain | EGF_CA | 5.35e-03 | 99 | 132 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 5.54e-03 | 100 | 132 | 4 | PS00010 | |
| Domain | SMAD_dom-like | 5.58e-03 | 16 | 132 | 2 | IPR017855 | |
| Domain | - | 5.58e-03 | 16 | 132 | 2 | 2.60.200.10 | |
| Domain | Small_GTPase | 5.60e-03 | 160 | 132 | 5 | IPR001806 | |
| Domain | WD40_repeat_CS | 6.21e-03 | 164 | 132 | 5 | IPR019775 | |
| Domain | Hemopexin_CS | 6.29e-03 | 17 | 132 | 2 | IPR018486 | |
| Pubmed | Maturation of HIV envelope glycoprotein precursors by cellular endoproteases. | 5.72e-08 | 3 | 135 | 3 | 11063880 | |
| Pubmed | Retroviral envelope glycoprotein processing: structural investigation of the cleavage site. | 2.28e-07 | 4 | 135 | 3 | 9521771 | |
| Pubmed | 5.69e-07 | 5 | 135 | 3 | 23028956 | ||
| Pubmed | 5.69e-07 | 5 | 135 | 3 | 11380615 | ||
| Pubmed | 5.69e-07 | 5 | 135 | 3 | 18664504 | ||
| Pubmed | 5.69e-07 | 5 | 135 | 3 | 27909076 | ||
| Pubmed | PRDM16/MEL1: a novel Smad binding protein expressed in murine embryonic orofacial tissue. | 1.13e-06 | 6 | 135 | 3 | 17467076 | |
| Pubmed | 1.13e-06 | 6 | 135 | 3 | 8940009 | ||
| Pubmed | DGCR2 SDK2 EMC1 XPO4 SLC7A6 IVNS1ABP KCTD5 ZNF516 AGAP7P MAP4K4 AGAP4 AGAP6 | 1.15e-06 | 529 | 135 | 12 | 14621295 | |
| Pubmed | 1.98e-06 | 7 | 135 | 3 | 10409610 | ||
| Pubmed | 1.98e-06 | 7 | 135 | 3 | 7819324 | ||
| Pubmed | STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling. | 1.98e-06 | 7 | 135 | 3 | 10757800 | |
| Pubmed | Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. | 3.16e-06 | 8 | 135 | 3 | 9885250 | |
| Pubmed | 3.16e-06 | 8 | 135 | 3 | 17428193 | ||
| Pubmed | 3.16e-06 | 8 | 135 | 3 | 10037747 | ||
| Pubmed | The activation and physiological functions of the proprotein convertases. | 4.72e-06 | 9 | 135 | 3 | 18343183 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 4.72e-06 | 9 | 135 | 3 | 12640130 | |
| Pubmed | The biology and therapeutic targeting of the proprotein convertases. | 4.72e-06 | 9 | 135 | 3 | 22679642 | |
| Pubmed | The prohormone theory and the proprotein convertases: it is all about serendipity. | 4.72e-06 | 9 | 135 | 3 | 21805236 | |
| Pubmed | 4.72e-06 | 9 | 135 | 3 | 21805237 | ||
| Pubmed | 4.72e-06 | 9 | 135 | 3 | 23775089 | ||
| Pubmed | 4.72e-06 | 9 | 135 | 3 | 8698813 | ||
| Pubmed | 6.73e-06 | 10 | 135 | 3 | 16163737 | ||
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 6.73e-06 | 10 | 135 | 3 | 20664521 | |
| Pubmed | ASNSD1 EPPK1 CEACAM5 NUP210L SYNE1 DNAH2 HEATR1 IVNS1ABP RACK1 ODR4 EML1 TMCO3 DMBT1 | 8.17e-06 | 754 | 135 | 13 | 35906200 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 9.22e-06 | 11 | 135 | 3 | 15381706 | |
| Pubmed | 9.22e-06 | 11 | 135 | 3 | 11483621 | ||
| Pubmed | A family of 12 human genes containing oxysterol-binding domains. | 1.23e-05 | 12 | 135 | 3 | 11735225 | |
| Pubmed | An oxysterol-binding protein family identified in the mouse. | 1.23e-05 | 12 | 135 | 3 | 12215260 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 21478675 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 29321361 | ||
| Pubmed | Bacterial protein domains with a novel Ig-like fold target human CEACAM receptors. | 1.50e-05 | 2 | 135 | 2 | 33522633 | |
| Pubmed | MMP-2 and MMP-13 affect vasculogenic mimicry formation in large cell lung cancer. | 1.50e-05 | 2 | 135 | 2 | 28766880 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 12270924 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 33813765 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 19461083 | ||
| Pubmed | [SMAD3 inhibits the expression of MMP-2 in mouse embryonic fibroblasts]. | 1.50e-05 | 2 | 135 | 2 | 16018191 | |
| Pubmed | Sidekick-1 is upregulated in glomeruli in HIV-associated nephropathy. | 1.50e-05 | 2 | 135 | 2 | 15213259 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 37882714 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 8898078 | ||
| Pubmed | Definition of the critical domains required for homophilic targeting of mouse sidekick molecules. | 1.50e-05 | 2 | 135 | 2 | 15703275 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 30150416 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 14550562 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 30177817 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 30321907 | ||
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 1.50e-05 | 2 | 135 | 2 | 21531043 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 16678258 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 18061232 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 29760215 | ||
| Pubmed | SETDB1 regulates SMAD7 expression for breast cancer metastasis. | 1.50e-05 | 2 | 135 | 2 | 30545440 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 2322568 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 8335106 | ||
| Pubmed | The relationship of metalloproteinase gene polymorphisms and lung cancer. | 1.50e-05 | 2 | 135 | 2 | 23465389 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 8468318 | ||
| Pubmed | Sidekicks: synaptic adhesion molecules that promote lamina-specific connectivity in the retina. | 1.50e-05 | 2 | 135 | 2 | 12230981 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 15905509 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 14985349 | ||
| Pubmed | Mutation analysis of the Smad3 gene in human osteoarthritis. | 1.50e-05 | 2 | 135 | 2 | 12939660 | |
| Pubmed | Molecular basis of sidekick-mediated cell-cell adhesion and specificity. | 1.50e-05 | 2 | 135 | 2 | 27644106 | |
| Pubmed | 1.59e-05 | 13 | 135 | 3 | 27713690 | ||
| Pubmed | 2.02e-05 | 14 | 135 | 3 | 22453919 | ||
| Pubmed | 2.52e-05 | 15 | 135 | 3 | 6101098 | ||
| Pubmed | Imaging proprotein convertase activities and their regulation in the implanting mouse blastocyst. | 3.09e-05 | 16 | 135 | 3 | 20876279 | |
| Pubmed | Biglycan and decorin differentially regulate signaling in the fetal membranes. | 3.09e-05 | 16 | 135 | 3 | 24373743 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 17876296 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 18403125 | ||
| Pubmed | Expression and significance of TGF-beta1/Smad signaling pathway in children with IgA nephropathy. | 4.48e-05 | 3 | 135 | 2 | 19693466 | |
| Pubmed | Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin. | 4.48e-05 | 3 | 135 | 2 | 29730765 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 25578880 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 7876312 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 8670066 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 26395178 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 17587297 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 18971037 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 25409014 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 4.48e-05 | 3 | 135 | 2 | 10788707 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 19590752 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 4.48e-05 | 3 | 135 | 2 | 7621815 | |
| Pubmed | Inhibitory potency and specificity of subtilase-like pro-protein convertase (SPC) prodomains. | 4.48e-05 | 3 | 135 | 2 | 11723118 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 28209735 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 19562509 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 10050053 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 16187293 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 4.48e-05 | 3 | 135 | 2 | 10473538 | |
| Pubmed | RACK1 silencing attenuates renal fibrosis by inhibiting TGF-β signaling. | 4.48e-05 | 3 | 135 | 2 | 29039466 | |
| Pubmed | miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis. | 4.48e-05 | 3 | 135 | 2 | 26040904 | |
| Pubmed | Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancer. | 4.48e-05 | 3 | 135 | 2 | 33682011 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 29233829 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 29122006 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 24636138 | ||
| Pubmed | Inhibition of Smad signaling is implicated in cleft palate induced by all-trans retinoic acid. | 4.48e-05 | 3 | 135 | 2 | 21555266 | |
| Pubmed | Thymosin beta4 promotes matrix metalloproteinase expression during wound repair. | 4.48e-05 | 3 | 135 | 2 | 16607611 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 12839562 | ||
| Pubmed | Multiple exportins influence thyroid hormone receptor localization. | 4.48e-05 | 3 | 135 | 2 | 25911113 | |
| Pubmed | Epinephrine-induced MMP expression is different between skeletal fibroblasts and myoblasts. | 4.48e-05 | 3 | 135 | 2 | 21858843 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 18434746 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 37225849 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 4.48e-05 | 3 | 135 | 2 | 9204703 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 21881589 | ||
| GeneFamily | Proprotein convertase subtilisin/kexin family | 1.27e-05 | 9 | 98 | 3 | 973 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 3.28e-05 | 12 | 98 | 3 | 670 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 8.69e-05 | 3 | 98 | 2 | 287 | |
| GeneFamily | Exportins | 6.00e-04 | 7 | 98 | 2 | 547 | |
| GeneFamily | Immunoglobulin like domain containing | 6.39e-04 | 193 | 98 | 6 | 594 | |
| GeneFamily | ArfGAPs | 7.49e-04 | 33 | 98 | 3 | 395 | |
| GeneFamily | SMAD family | 7.97e-04 | 8 | 98 | 2 | 750 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.84e-03 | 161 | 98 | 5 | 593 | |
| GeneFamily | WD repeat domain containing | 3.03e-03 | 262 | 98 | 6 | 362 | |
| GeneFamily | Dyneins, axonemal | 3.75e-03 | 17 | 98 | 2 | 536 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 3.75e-03 | 17 | 98 | 2 | 1291 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.20e-03 | 18 | 98 | 2 | 91 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.28e-03 | 206 | 98 | 5 | 682 | |
| GeneFamily | RAB, member RAS oncogene GTPases | 5.29e-03 | 65 | 98 | 3 | 388 | |
| GeneFamily | DNA polymerases | 6.83e-03 | 23 | 98 | 2 | 535 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 6.83e-03 | 23 | 98 | 2 | 1288 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 7.43e-03 | 24 | 98 | 2 | 891 | |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 7.43e-03 | 24 | 98 | 2 | 906 | |
| GeneFamily | Fibronectin type III domain containing | 1.12e-02 | 160 | 98 | 4 | 555 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.19e-02 | 163 | 98 | 4 | 590 | |
| Coexpression | DESCARTES_FETAL_SPLEEN_MEGAKARYOCYTES | 2.04e-06 | 114 | 134 | 7 | M40293 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rprm|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.40e-08 | 120 | 135 | 7 | 2b7596946f9268c4202348adf3069decd8313bb0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-08 | 184 | 135 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-08 | 184 | 135 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-08 | 184 | 135 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte2_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.33e-07 | 165 | 135 | 7 | d2ab667ff53f538b12ee4e07ea4b4d118600a228 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.61e-07 | 169 | 135 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-06 | 185 | 135 | 7 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-06 | 186 | 135 | 7 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 1.69e-06 | 187 | 135 | 7 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.75e-06 | 188 | 135 | 7 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | severe_influenza-Platelet|World / disease group, cell group and cell class (v2) | 1.75e-06 | 188 | 135 | 7 | b54632baa682aaf51100d44e7f114a54d5edd695 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-06 | 189 | 135 | 7 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-06 | 189 | 135 | 7 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.02e-06 | 192 | 135 | 7 | b877d14be9d04ab0010e340909e3a23de92613db | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.09e-06 | 193 | 135 | 7 | a2fb7482e79d6ce5b6b1d9d0c0811d1c58b4d85d | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.09e-06 | 193 | 135 | 7 | 1d724ccb745cfc624119dd6003d53b84b17c94b0 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.24e-06 | 195 | 135 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.39e-06 | 197 | 135 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-06 | 199 | 135 | 7 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.64e-06 | 200 | 135 | 7 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.64e-06 | 200 | 135 | 7 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-06 | 200 | 135 | 7 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-06 | 200 | 135 | 7 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Glia_progenitor_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.64e-06 | 200 | 135 | 7 | 4b937b1d0179d1d0e51931f35720e205d460a07e | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.40e-06 | 140 | 135 | 6 | 17005ca714ba03d7528fe7979ffb4654a46b666c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.80e-06 | 151 | 135 | 6 | f4f7156b2c0cfc78fd1841e07c9915d97ced561f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.34e-06 | 153 | 135 | 6 | 0a4fbe46125b05ee235deb528855808c2bf33cba | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.82e-06 | 158 | 135 | 6 | 944c5fe625f965dd6153dbcbf5577f99ad343983 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 167 | 135 | 6 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte2_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.34e-05 | 170 | 135 | 6 | 3886a77bc3ddbeb42a8149b759fe578871676d6e | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.38e-05 | 171 | 135 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations) | 1.85e-05 | 180 | 135 | 6 | 25ad95c3c30e3b82abe93bd77ba003f5c2241f7c | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 183 | 135 | 6 | 6ca7c2d7c56e0f1b9038ba677b4c1c3dfd63bfce | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.03e-05 | 183 | 135 | 6 | 6cbc88c27dc957d182526e84824f70c8e860bf74 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 183 | 135 | 6 | 18040d0653286071df959513c63d94b555a5d00a | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.09e-05 | 184 | 135 | 6 | ba65e3972b2b8d825a2c1a9d03d092cc1afad073 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.09e-05 | 184 | 135 | 6 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.16e-05 | 185 | 135 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-05 | 186 | 135 | 6 | 740fd06bcd3b24e6ff2ecf8080f378afc3e95084 | |
| ToppCell | megakaryocytic-Megakaryocyte|World / Lineage and Cell class | 2.22e-05 | 186 | 135 | 6 | acd15a169b6122b28cc99ef34de10701edcfedfe | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-05 | 186 | 135 | 6 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-05 | 186 | 135 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-05 | 186 | 135 | 6 | 5ab43a298d23238b34e898d11decf0ad81d1b14e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-05 | 187 | 135 | 6 | 48bfdb3504c3fefe5db3abac4b790c369680ab4e | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-05 | 187 | 135 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-05 | 187 | 135 | 6 | 958402fcc78f4c7a7d13d659d776f3817137975f | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 2.36e-05 | 188 | 135 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.36e-05 | 188 | 135 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-05 | 188 | 135 | 6 | a6ed43fdd42d681c9fbb2fb368947ab7e41d8d7c | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-05 | 188 | 135 | 6 | 54550313db78b3b5b572fa1e67092c8f6f33aab5 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.36e-05 | 188 | 135 | 6 | 0eca3dc93724e23b71e687fc24fa9f1e89bdef6a | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.36e-05 | 188 | 135 | 6 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.36e-05 | 188 | 135 | 6 | 9ce3e1fffce87ad19812ecbf9b7f9935a975d676 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.43e-05 | 189 | 135 | 6 | d357fa946b9d6af46c15402f68758fb9c747bcaf | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.43e-05 | 189 | 135 | 6 | 8b4a9434d7b7ca8cf74712227407ed7c96ce02f8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-05 | 189 | 135 | 6 | fac5c291a9a87418bb0878c3d624829bdbf1f428 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-05 | 189 | 135 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.43e-05 | 189 | 135 | 6 | fe958fdf9963c2dfe270f67f0da36b3264d0017c | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 2.43e-05 | 189 | 135 | 6 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-05 | 189 | 135 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 2.43e-05 | 189 | 135 | 6 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | 2.43e-05 | 189 | 135 | 6 | 711181ca3b9102fb155168b646b0a9b09ff215b2 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.51e-05 | 190 | 135 | 6 | e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.51e-05 | 190 | 135 | 6 | f32d66c0e74e0a2a23ecb857c4daf0d8573a806c | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-05 | 190 | 135 | 6 | 68ba1934b2b3f0cec8efd229fe1db6e8be8a26b0 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.51e-05 | 190 | 135 | 6 | b79ffd05806244a9790cd04c66fb4f92c824e69f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-05 | 190 | 135 | 6 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-05 | 190 | 135 | 6 | 3dcadabbefe0128a5f30ab51234f049ab4d870c6 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-05 | 190 | 135 | 6 | 010d7d13a3c16e614c36720ef690a505b9f3f7aa | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 191 | 135 | 6 | 5a5b5402a077b3189ca156f2bac5f47ad780aebf | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 191 | 135 | 6 | 78bcce497920cc5b3bef083eab50deb1cc82cd2e | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.58e-05 | 191 | 135 | 6 | 7edc22e7e70697fb22690699efb352577162709b | |
| ToppCell | LAM-Epithelial-AirwayEpi|LAM / Condition, Lineage and Cell class | 2.66e-05 | 192 | 135 | 6 | 7404fc65be3b7bd09447725b43fa31819004dfee | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.74e-05 | 193 | 135 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.74e-05 | 193 | 135 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | severe_COVID-19-Platelet|World / disease group, cell group and cell class (v2) | 2.74e-05 | 193 | 135 | 6 | a598a0665652cc365eb08e413a711c929b80fec7 | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Megakaryocyte|World / Lineage, cell class and subclass | 2.74e-05 | 193 | 135 | 6 | 352cd442b6e62f09b6d22a139774067873644594 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 2.74e-05 | 193 | 135 | 6 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 194 | 135 | 6 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 194 | 135 | 6 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.82e-05 | 194 | 135 | 6 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.90e-05 | 195 | 135 | 6 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.90e-05 | 195 | 135 | 6 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 196 | 135 | 6 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 196 | 135 | 6 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.98e-05 | 196 | 135 | 6 | 66ba31b74953726e9c314f6d8fe3f75d3762e23a | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.98e-05 | 196 | 135 | 6 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.98e-05 | 196 | 135 | 6 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.98e-05 | 196 | 135 | 6 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.98e-05 | 196 | 135 | 6 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | severe_COVID-19-Platelet|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.98e-05 | 196 | 135 | 6 | 2b835fc3db81550555cbbcb3e823d9197ee35662 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.98e-05 | 196 | 135 | 6 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | (05)_Ciliated|World / shred by cell type and Timepoint | 3.07e-05 | 197 | 135 | 6 | fee3cd16af8eea697cd64e8f64af505aaa2ac4b0 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.07e-05 | 197 | 135 | 6 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 3.07e-05 | 197 | 135 | 6 | fd7bdfa6bf5966ebc11fdd13915769429540ddbf | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.07e-05 | 197 | 135 | 6 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.16e-05 | 198 | 135 | 6 | 3bc05b8d97a7219af40db7a11aa271f02e74fca5 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.25e-05 | 199 | 135 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | medial-Epithelial-Ciliated-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.25e-05 | 199 | 135 | 6 | 526002f16bbf61cf086278d45a401cc0b0b757a8 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.25e-05 | 199 | 135 | 6 | f34c15df58fbdc6c90e30800e26fabbf828ad10b | |
| Drug | D3273 | 1.40e-06 | 94 | 134 | 7 | CID005464587 | |
| Drug | Azathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 2.50e-06 | 196 | 134 | 9 | 5627_UP | |
| Disease | cerebral palsy (implicated_via_orthology) | 1.05e-05 | 10 | 133 | 3 | DOID:1969 (implicated_via_orthology) | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 3.16e-05 | 80 | 133 | 5 | DOID:6432 (biomarker_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 6.03e-05 | 3 | 133 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | complement C5B-C6 complex measurement | 6.03e-05 | 3 | 133 | 2 | EFO_0020279 | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 6.03e-05 | 3 | 133 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | hippocampal volume | 6.33e-05 | 297 | 133 | 8 | EFO_0005035 | |
| Disease | Craniofacial Abnormalities | 7.82e-05 | 156 | 133 | 6 | C0376634 | |
| Disease | gastric ulcer (biomarker_via_orthology) | 1.12e-04 | 21 | 133 | 3 | DOID:10808 (biomarker_via_orthology) | |
| Disease | arteriosclerosis (is_implicated_in) | 3.67e-04 | 31 | 133 | 3 | DOID:2349 (is_implicated_in) | |
| Disease | behavioural disinhibition measurement | 3.74e-04 | 75 | 133 | 4 | EFO_0006946 | |
| Disease | anxiety, vitamin D measurement | 4.17e-04 | 7 | 133 | 2 | EFO_0004631, EFO_0005230 | |
| Disease | urate measurement, bone density | SYNE1 THAP9 SFMBT2 CCER1 SLC6A2 KIRREL3 ZNF516 DMBT1 CABIN1 UTRN | 5.15e-04 | 619 | 133 | 10 | EFO_0003923, EFO_0004531 |
| Disease | coronary artery disease | DNAH10 DOCK8 F13A1 FES C5 EML1 MMP13 CABIN1 PRDM16 ADGRL3 GABBR1 SMAD3 SMAD7 PLCE1 | 1.02e-03 | 1194 | 133 | 14 | EFO_0001645 |
| Disease | amino acid measurement | 1.03e-03 | 678 | 133 | 10 | EFO_0005134 | |
| Disease | Colorectal Neoplasms | 1.64e-03 | 277 | 133 | 6 | C0009404 | |
| Disease | glucose metabolism measurement, age-related hearing impairment | 1.68e-03 | 52 | 133 | 3 | EFO_0005782, EFO_0009367 | |
| Disease | Metabolic Bone Disorder | 1.77e-03 | 14 | 133 | 2 | C0005944 | |
| Disease | ovarian carcinoma (is_implicated_in) | 2.04e-03 | 15 | 133 | 2 | DOID:4001 (is_implicated_in) | |
| Disease | Osteopenia | 2.04e-03 | 15 | 133 | 2 | C0029453 | |
| Disease | Pulmonary Emphysema | 2.62e-03 | 17 | 133 | 2 | C0034067 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 3.63e-03 | 20 | 133 | 2 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | ST2 protein measurement | 4.00e-03 | 21 | 133 | 2 | EFO_0010599 | |
| Disease | periodontitis (biomarker_via_orthology) | 4.00e-03 | 21 | 133 | 2 | DOID:824 (biomarker_via_orthology) | |
| Disease | Nasopharyngeal carcinoma | 4.39e-03 | 22 | 133 | 2 | C2931822 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KGNVVLAQLLIWYGV | 611 | Q96P64 | |
| ILWDGFTGQRSKVYQ | 496 | Q8NHY2 | |
| WKTGKIQLYQGTDAT | 501 | Q8IUX8 | |
| LSQQVREQYGKWSKG | 781 | Q9UHX3 | |
| TSRWLVDTGNVKGYV | 621 | Q9NXL2 | |
| SWYKGERVDGNRQII | 66 | P06731 | |
| GLWVIYATEQNNGKI | 271 | Q9HAR2 | |
| KETWGLQETLYGFVQ | 241 | Q8TC90 | |
| YVLWKQIIERNGGVL | 711 | Q86XH1 | |
| LRNTQWVFGIVVYTG | 276 | Q9NTI2 | |
| KGNVVLAQLLIWYGV | 611 | Q5VW22 | |
| TQIFGVGVKTADRWY | 241 | Q9NP87 | |
| ELWTLGEGQVVRVKY | 211 | P08253 | |
| SGYFLWTKVRNVVLG | 866 | Q7Z401 | |
| GAQGVILVYDIANRW | 86 | Q8WXH6 | |
| GAQGVILVYDIANRW | 86 | Q12829 | |
| GAQGVILVYDIANRW | 86 | P0C0E4 | |
| GYTDNLVRVWQVTIG | 301 | P63244 | |
| NVGGKYVKLQIWDTA | 56 | P20338 | |
| FYRQQKWASGVIAIA | 391 | Q86VS3 | |
| QNWRVYDVLVLKGSQ | 116 | Q5SQ64 | |
| LSWGRYQLVVTQRKE | 621 | O75106 | |
| LWYVKQCGGTTRIIS | 186 | P27338 | |
| TYGRITKDVVLQWGE | 1146 | O95819 | |
| NGKLYTKVINWVQRS | 191 | Q9Y6Y0 | |
| VIEQSYNETWLGRQG | 51 | P14672 | |
| NYGQEVWLRLAKGTI | 1196 | Q13201 | |
| QGAYGIVWKAVDRRT | 21 | Q8TD08 | |
| WTLIEQLQGGSYKKI | 536 | Q9UBS5 | |
| AGYGIWNTAIQSAIR | 436 | Q5FYB0 | |
| YFEWAAQVVKGLQGT | 146 | Q8N4P3 | |
| AALRQKVQQWYTAVG | 371 | Q5HYC2 | |
| ATKQEYWGNGTVTVK | 181 | Q6Q8B3 | |
| GVTINVWGRKVLLYD | 341 | Q5JST6 | |
| TVTEGGVKQEYRTWN | 136 | A6NHQ2 | |
| WKRGYTGKNIVVTIL | 156 | Q92824 | |
| VQAAWKRGYTGKNVV | 186 | P29122 | |
| QVGILRQWQLTLYGS | 601 | Q16549 | |
| TGKTLLFSGNQVWRY | 391 | P45452 | |
| NGLTRWAKEIENGVY | 206 | Q5SWX8 | |
| INSCIRIGKEWQGIY | 276 | O60658 | |
| VSYSGLVNDNWKRGK | 176 | Q969I3 | |
| KKYRVLGINEWQNTG | 186 | Q9H1A3 | |
| GEVNDIKTRSWSYGQ | 216 | P00488 | |
| WKGYTGKTITDVINI | 141 | P06744 | |
| QKLYWAVTGRGVIER | 1931 | P98164 | |
| KRINWRTVLSGGSLY | 126 | P54368 | |
| GTGVIRKEGRQLYWT | 266 | A8MVW0 | |
| LLIYKTQKNGQWVGT | 176 | Q9BZF1 | |
| EIVWYRVTDGGTIKQ | 56 | Q96ID5 | |
| GKTLLLDAYRVWQQG | 1856 | Q9Y6J0 | |
| LDAYRVWQQGQKGVA | 1861 | Q9Y6J0 | |
| QAEVGEWLRIGNKYI | 76 | A6NFR6 | |
| QKQGASVETLLGYSW | 656 | Q8NF50 | |
| SWYKGERVDGNRQIV | 66 | P13688 | |
| QAYKGWQLSTKEGVR | 1126 | Q6P158 | |
| TGRVVGILQKNWRDY | 331 | Q8TF46 | |
| QKRGNSTVYEWRTGT | 231 | Q96JB5 | |
| IFLGKTWGQEQTYVI | 11 | P01031 | |
| TLWGVGQSNYLEKNR | 61 | Q53FE4 | |
| IGENFAYVQIKTIWS | 456 | Q16850 | |
| KGNVVLAQLLIWYGV | 611 | Q5VUJ5 | |
| QRKLWVGYQYVITGR | 181 | P98153 | |
| KDVIIWGNISGNNYV | 306 | Q5I0G3 | |
| WGNISGNNYVDLRKT | 311 | Q5I0G3 | |
| VTLNRERGQWYLVGT | 651 | P48740 | |
| IGWLVAQEGVKSYQS | 471 | Q9NWL6 | |
| SVSKWVRLNVGGTYF | 41 | Q9NXV2 | |
| IIWLRKGEVINGATY | 181 | Q8IZU9 | |
| VGGDVQILNKYDSWI | 241 | O00219 | |
| VQEVGGSYWQRVTLI | 1196 | Q9H583 | |
| ILVWGKGTNRISYAV | 441 | O00423 | |
| YVWKGINLIRTIQGA | 221 | Q05BV3 | |
| YVWKGLNLVRTIQGA | 221 | Q6ZMW3 | |
| QVGKFDWRQQYVGKV | 26 | Q8N766 | |
| KLNITNIWVLDYFGG | 191 | O75629 | |
| DWVKARNKVGQVGYV | 506 | O94868 | |
| QGRVEVLYRGSWGTV | 1261 | Q9UGM3 | |
| KRLNWNSLGIGDYIT | 746 | Q8IVF4 | |
| TNYRDEIVNQIWIGK | 3326 | Q9P225 | |
| LEKNGIITGYQISWE | 996 | Q7Z5N4 | |
| GVYSSKVTEWTLQGV | 776 | Q58EX2 | |
| ALWLIYKQGGVTQEA | 516 | Q08357 | |
| RIRQGWTYGIQQDVK | 1011 | Q92736 | |
| DQWVKLNLGTVGFYR | 576 | P55786 | |
| TVVYVVGKAGRQHWQ | 896 | Q8NG08 | |
| GQRWIEHYGEIVIKN | 696 | Q9H4L5 | |
| GNRWSLEVGQVYVIT | 366 | Q5VU65 | |
| VVTVNNKLYVIGGWT | 431 | Q3ZCT8 | |
| QERIKGWGLKYLSVQ | 461 | A6NES4 | |
| QGKQEYVLSVLWDGL | 486 | P07332 | |
| RSSYVITTKIFWGGQ | 151 | O43448 | |
| YLSQQWAKASGRGEV | 26 | P13984 | |
| LGQYNREGAATVWKI | 116 | P23975 | |
| LNWLLNVYDTGRTGK | 2936 | P46939 | |
| GTSWYIILKGSVNVV | 391 | Q8WZA2 | |
| QYGRKTGLKISVLWT | 146 | Q8N4V2 | |
| GIYALWKRSIQSIQK | 66 | Q7Z6W1 | |
| SQYIKWIVSAGLAQV | 606 | Q6UWJ1 | |
| KWVQYTAGKQTGIEV | 186 | Q8NF91 | |
| GALSKWTSYQDGVRQ | 3386 | Q8NF91 | |
| IGLTAWSYIDQKRNG | 356 | Q9P212 | |
| QGQAAVTIQKVWKGY | 206 | A6NCM1 | |
| NQAGAGSWLKYIRVA | 161 | Q9HAZ2 | |
| VKYGRFQGQRVSAWE | 821 | P58107 | |
| GVVWLIRNGSIYINE | 201 | Q9UK23 | |
| WRDGSGQEKYRLVVV | 6 | P62070 | |
| YQIIEDAGNKGIWSR | 96 | Q9H1D9 | |
| LWYALSAGGNVVNKV | 36 | Q96K37 | |
| NVIIGKLWIEQYGTV | 241 | Q9H1P3 | |
| DGTLRLWQTVVGKTY | 286 | Q9Y3F4 | |
| GWLTRLLQTKNYDIG | 411 | Q13501 | |
| GSRVVAKYKDGNQVW | 261 | Q15047 | |
| LGQALQDSRNYGWKV | 226 | Q16881 | |
| YQAWQLATRGKVAEP | 416 | Q92618 | |
| QISFVKGWGQCYTRQ | 396 | O15105 | |
| NTYGRITKDVVLQWG | 1266 | Q9UKE5 | |
| YGRKQVSWIIFLKIG | 36 | Q8N2B8 | |
| DTEGSQWIIGYLLQK | 671 | Q9C0E2 | |
| ILRINRAGQWYVETG | 211 | Q5TC79 | |
| LVNDTKKWGARVVYG | 2766 | O60673 | |
| RKDLALWTVQRQYGV | 666 | Q9H5L6 | |
| KDRIKQGWTYGIQQD | 996 | Q15413 | |
| FVKGWGAEYRRQTVT | 376 | P84022 | |
| GLVYNLVKISWELQG | 436 | C9JQI7 | |
| VGVSKQDIREQIWGY | 6 | Q2M296 | |
| FQYWIVSVIENVGGR | 201 | Q5VUG0 | |
| KVNENWYEGRITGTG | 486 | O60504 | |
| NYWNTKIGLQVKELG | 131 | A6NFE2 | |
| IVGLQVRYGKVWSDY | 61 | O60844 | |
| VGLSVVGQLYLRWKE | 401 | Q92536 | |
| TQYVKWTNDKSLGGI | 36 | Q5R3I4 | |
| VFIGKIITNLKYWGR | 591 | Q9UIA9 | |
| IVKWGGQEYSVTTLS | 6 | Q8WVY7 | |
| LYVFSVWVGKNGINS | 361 | Q9HD43 | |
| WGLLNVTQKGLYRDV | 31 | Q8IVC4 | |
| ISYWGEQIGQKIRKI | 221 | Q13488 | |
| REVQKQETWVFLVYG | 81 | Q2WGJ8 | |
| QWNKIYSVETGLLGT | 26 | Q8N9L7 | |
| VAGWGTTAARRVKYN | 171 | O43240 | |
| IGRVVVLQAYTKGWL | 1061 | Q8WXR4 | |
| YSDRVKTGVTGEQIW | 1501 | P52179 |